Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001415889-24-023550

Chief Medical Officer sold 2,220 shares at $38.93 ($86,425)

  • Chief Medical Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lizzul Paul F. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-14 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 17,618 D
2024-09-16 Sale : show line 2 in the form 10b5-1 −2,220 $38.93 $86,425 15,398 D
Open-market sales · 2,220 sh · avg $38.93 · $86,425

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-14 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Unit −6,000 0 D
Loading xslF345X05/form4-09172024_100907.xml…